chr5-163463895-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001142556.2(HMMR):āc.86T>Cā(p.Leu29Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000641 in 1,498,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001142556.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMMR | NM_001142556.2 | c.86T>C | p.Leu29Ser | missense_variant | 2/18 | ENST00000393915.9 | NP_001136028.1 | |
HMMR | NM_012484.3 | c.86T>C | p.Leu29Ser | missense_variant | 2/18 | NP_036616.2 | ||
HMMR | NM_012485.3 | c.86T>C | p.Leu29Ser | missense_variant | 2/17 | NP_036617.2 | ||
HMMR | NM_001142557.2 | c.12+3157T>C | intron_variant | NP_001136029.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMMR | ENST00000393915.9 | c.86T>C | p.Leu29Ser | missense_variant | 2/18 | 1 | NM_001142556.2 | ENSP00000377492.4 | ||
HMMR | ENST00000520345 | c.-212T>C | 5_prime_UTR_variant | 2/6 | 2 | ENSP00000428481.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000169 AC: 3AN: 177698Hom.: 0 AF XY: 0.0000306 AC XY: 3AN XY: 97948
GnomAD4 exome AF: 0.0000706 AC: 95AN: 1346228Hom.: 0 Cov.: 22 AF XY: 0.0000658 AC XY: 44AN XY: 668994
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74350
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at